adMare BioInnovations (adMare) is pleased to announce that 22 participants representing a wide range of life sciences enterprises from across the country were selected to join Cohort V of the adMare Academy Executive Institute.
adMare builds life sciences companies, ecosystems, and talent to drive the growth of the Canadian life sciences industry into a sustainable and world-leader sector. The adMare Academy offers unique and substantive programs for highly qualified personnel, from undergraduates through to senior executives. The Executive Institute, a custom-designed program, has been widely recognized for its contribution to developing leadership capacity in the Canadian life sciences sector. Over 4 previous cohorts, the program has helped develop 67 leaders, with numerous alumni successfully leading their organizations through tremendous growth periods and achieving commercial successes.
adMare recognizes that diversity is Canada’s strength and ensures that adMare Academy programs help address the gender gap within leadership positions and build opportunities for underrepresented groups. The Executive Institute program received a record number of applications of outstanding quality this year, with 22 remarkable persons selected for the 2022-2023 program.
Four of the participants Cohort V are located in British Columbia:
- Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada, Vancouver, BC
- Gregory Block, Senior Vice President Corporate Development, Notch Therapeutics, Vancouver, BC
- Jennifer Cox, Senior Director, Chinook Therapeutics, Vancouver, BC
- Michael Riedel, Vice President, Quality , STEMCELL Technologies, Vancouver, BC
The other participants are from Alberta, Ontario, Quebec, and Nova Scotia. Together, the participants have a variety of functional responsibilities, and are engaged in various types and sizes of life sciences organizations.
Click Here for more information about the program and to view the full list of Cohort V participants.